An open-label, randomized, two treatment, cross over, single dose study to determine the effect of food on the pharmacokinetics of a fixed dose combination of aliskiren (SPP100)/ amlodipine/ hydrochlorothiazide 300/10/25 mg tablet in healthy subjects under fasted and fed condition
Latest Information Update: 01 Sep 2016
At a glance
- Drugs Aliskiren/amlodipine/hydrochlorothiazide (Primary)
- Indications Hypertension
- Focus Adverse reactions; Pharmacokinetics
- 04 Oct 2011 New trial record